Jason A. Sager

1.5k total citations
11 papers, 841 citations indexed

About

Jason A. Sager is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Jason A. Sager has authored 11 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Jason A. Sager's work include Cell death mechanisms and regulation (2 papers), DNA Repair Mechanisms (2 papers) and Computational Drug Discovery Methods (2 papers). Jason A. Sager is often cited by papers focused on Cell death mechanisms and regulation (2 papers), DNA Repair Mechanisms (2 papers) and Computational Drug Discovery Methods (2 papers). Jason A. Sager collaborates with scholars based in United States and Italy. Jason A. Sager's co-authors include Bert Vogelstein, Kenneth W. Kinzler, Alberto Bardelli, Victor E. Velculescu, Sanford D. Markowitz, Christoph Lengauer, D. Williams Parsons, Zhenghe Wang, Tian‐Li Wang and Dong Shen and has published in prestigious journals such as Science, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Jason A. Sager

10 papers receiving 829 citations

Peers

Jason A. Sager
Anja Deutzmann United States
Vadym Zaberezhnyy United States
S Nakamori Japan
Jacqueline Lesperance United States
Betsy Nelson United States
Niranjan Yanamandra United States
Michele Dziubinski United States
Arild Holth Norway
Marjon A. Smit Netherlands
Yuanyan Wei China
Anja Deutzmann United States
Jason A. Sager
Citations per year, relative to Jason A. Sager Jason A. Sager (= 1×) peers Anja Deutzmann

Countries citing papers authored by Jason A. Sager

Since Specialization
Citations

This map shows the geographic impact of Jason A. Sager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason A. Sager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason A. Sager more than expected).

Fields of papers citing papers by Jason A. Sager

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason A. Sager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason A. Sager. The network helps show where Jason A. Sager may publish in the future.

Co-authorship network of co-authors of Jason A. Sager

This figure shows the co-authorship network connecting the top 25 collaborators of Jason A. Sager. A scholar is included among the top collaborators of Jason A. Sager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason A. Sager. Jason A. Sager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Daniels, Matthew H., David Brennan, Brian Johnston, et al.. (2024). Abstract PR003: DHX9 inhibition as a novel therapeutic for ovarian and breast cancer with loss-of-function mutations in the DNA damage repair genes BRCA1 or BRCA2. Cancer Research. 84(1_Supplement). PR003–PR003.
2.
Camidge, D. Ross, Roy S. Herbst, Michael S. Gordon, et al.. (2010). A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies. Clinical Cancer Research. 16(4). 1256–1263. 133 indexed citations
3.
Infante, Jeffrey R., E. Claire Dees, Howard A. Burris, et al.. (2010). Abstract 2775: A phase I study of LCL161, an oral IAP inhibitor, in patients with advanced cancer. Cancer Research. 70(8_Supplement). 2775–2775. 18 indexed citations
4.
Murdoch, David & Jason A. Sager. (2008). Will targeted therapy hold its promise? An evidence-based review. Current Opinion in Oncology. 20(1). 104–111. 38 indexed citations
5.
Camidge, D. Ross, Roy S. Herbst, Michael S. Gordon, et al.. (2007). A phase I safety and pharmacokinetic study of apomab, a human DR5 agonist antibody, in patients with advanced cancer. Journal of Clinical Oncology. 25(18_suppl). 3582–3582. 31 indexed citations
6.
Smith, Amos B., B. Scott Freeze, Matthew J. LaMarche, et al.. (2005). Discodermolide analogues as the chemical component of combination bacteriolytic therapy. Bioorganic & Medicinal Chemistry Letters. 15(15). 3623–3626. 26 indexed citations
7.
Bachman, Kurtis E., Jason A. Sager, Ian Cheong, et al.. (2005). Identification of compounds that inhibit growth of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine–resistant cancer cells. Molecular Cancer Therapeutics. 4(6). 1026–1030. 8 indexed citations
8.
Wang, Zhenghe, Dong Shen, D. Williams Parsons, et al.. (2004). Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers. Science. 304(5674). 1164–1166. 412 indexed citations
9.
Sager, Jason A. & Christoph Lengauer. (2003). New Paradigms for Cancer Drug Discovery?. Cancer Biology & Therapy. 2(4). 452–455. 6 indexed citations
10.
Sager, Jason A. & Christoph Lengauer. (2003). New Paradigms for Cancer Drug Discovery?. Cancer Biology & Therapy. 2(sup1). 177–180. 3 indexed citations
11.
Bardelli, Alberto, Saurabh Saha, Jason A. Sager, et al.. (2003). PRL-3 expression in metastatic cancers.. PubMed. 9(15). 5607–15. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anja Deutzmann Breakdown of academic impact, for papers by Vadym Zaberezhnyy Breakdown of academic impact, for papers by S Nakamori Breakdown of academic impact, for papers by Jacqueline Lesperance Breakdown of academic impact, for papers by Betsy Nelson Breakdown of academic impact, for papers by Niranjan Yanamandra Breakdown of academic impact, for papers by Michele Dziubinski Breakdown of academic impact, for papers by Arild Holth Breakdown of academic impact, for papers by Marjon A. Smit Breakdown of academic impact, for papers by Yuanyan Wei
Rankless by CCL
2026